Articles from BIOTECH Patent News (September 1, 2006)

Title	Author	Type	Words
Adenosine Therapeutics announces in-licensing of rights to technology for use in cardiac, cancer and vaccine applications.			329
Amgen obtains United States patent.			124
Aqua Med obtains United States patent.		Brief article	134
AstraZeneca obtains United States patent.			131
Biogemma obtains United States patent.		Brief article	69
CardioVascular announces patent notice of allowance for its catheter platform with stent deployment features technology.			500
Cargill obtains United States patent.			59
Cell Signalling obtains United States patent.			121
Cell Therapeutics announces worldwide license for treatment of women with non-small cell lung cancer.			737
ChemoCentryx obtains United States patent.			48
Columbia University in the City of New York obtains United States patent.			152
du Pont obtains United States patent.		Brief article	63
Elan obtains United States patent.			112
Genetics Institute obtains United States patent.			81
InViragen announces exclusive patent license agreement with CDC.			520
Lux Biosciences gains exclusive worldwide license for ophthalmic polyarylate patent estate from Rutgers.			858
Molecular biomarkers predicting efficacy of cancer therapy highlighted.			538
NanoLogix files six additional patent applications for hydrogen bioreactor technologies.			431
New York University obtains United States patent.		Brief article	135
NMT Medical appeals court's ruling in patent infringement lawsuit against Cardia.			359
NovaCal licenses anti-infective compounds for eye, ear and sinus infections to Alcon.			517
Novartis obtains United States patent.			70
Peregrine's phospholipid-targeted antibodies fused wth cytokines reduce tumor growth.			629
Pharmacopeia's delivery of advanced lead compounds to Organon triggers milestone payment.			655
Senomyx obtains United States patent.		Brief article	106
United States Court of Appeals denies rehearing request in dismissal of Tamoxifen Citrate antitrust lawsuits.			449
VCU researchers develop and patent method for measuring blood pressure.			623
Vical extends patent coverage for adjuvant to conventional vaccines.			393
Vical grants additional academic licenses for core technology.			416
Watson and Unimed settle lawsuit over testosterone gel.			510
Weil Gotshal litigators victorious in multi-billion dollar Erbitux patent case.			240
ZymoGenetics discusses detailed results from successful Phase 3 trial evaluating rhThrombin as treatment for surgical bleeding.			786